Free Trial

InnovAge (INNV) Set to Announce Earnings on Tuesday

→ Does this make you sick? (From Allegiance Gold) (Ad)

InnovAge (NASDAQ:INNV - Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of ($0.04) per share for the quarter. Persons interested in participating in the company's earnings conference call can do so using this link.

InnovAge (NASDAQ:INNV - Get Free Report) last announced its quarterly earnings data on Monday, February 5th. The company reported ($0.03) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.03). InnovAge had a negative net margin of 4.38% and a negative return on equity of 10.53%. The firm had revenue of $188.90 million for the quarter, compared to analysts' expectations of $181.51 million. During the same period last year, the firm earned ($0.07) earnings per share. On average, analysts expect InnovAge to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

InnovAge Trading Down 4.6 %

INNV stock traded down $0.17 during midday trading on Tuesday, reaching $3.55. The company's stock had a trading volume of 63,436 shares, compared to its average volume of 25,070. InnovAge has a 52 week low of $3.52 and a 52 week high of $8.05. The stock has a market cap of $482.44 million, a PE ratio of -14.20 and a beta of 0.15. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.26. The business's 50-day simple moving average is $4.46 and its 200-day simple moving average is $5.24.


Wall Street Analyst Weigh In

A number of brokerages have issued reports on INNV. The Goldman Sachs Group reduced their price objective on shares of InnovAge from $8.00 to $7.00 and set a "neutral" rating on the stock in a research note on Thursday, February 8th. JPMorgan Chase & Co. cut their target price on shares of InnovAge from $7.00 to $6.00 and set a "neutral" rating on the stock in a report on Wednesday, March 13th.

View Our Latest Stock Analysis on InnovAge

About InnovAge

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

Featured Stories

Earnings History for InnovAge (NASDAQ:INNV)

→ Does this make you sick? (From Allegiance Gold) (Ad)

Should you invest $1,000 in InnovAge right now?

Before you consider InnovAge, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.

While InnovAge currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: